Skip to main content
. 2019 Jan 20;49(3):265–276. doi: 10.1111/apt.15072

Figure 6.

Figure 6

A, Mean CDAI score through week 48, and mean changes from baseline at week 48 for B, CDAI, C, C‐reactive protein and D, faecal calprotectin for tofacitinib 10 mg b.d. All data represent full analysis set (observed). N represents the total number of patients analysed at each time point, n represents the number of patients with data at week 48, or at baseline and week 48. b.d., twice daily; CDAI, Crohn's disease activity index; SD, standard deviation